{"favorite_id": 3011, "calc_type": "calculator", "dosing": false, "full_title_en": "TNM Staging for Renal Cell Carcinoma", "short_title_en": "TNM RCC Staging", "medium_description_en": "Stages RCC based on tumor, lymph nodes, and metastases.", "short_description_en": "RCC staging.", "before_use": "", "instructions_en": "<p>This calculator is based on the 7th edition of the AJCC Cancer Staging Manual. The <calculator id=\"10122\">8th edition</calculator> is now recommended for use over this version.</p>", "purpose_en": ["Prognosis"], "disease_en": ["Chemotherapy", "Renal Cell Carcinoma"], "specialty_en": ["Hematology and Oncology", "Hospitalist Medicine", "Internal Medicine", "Nephrology", "Urology"], "chief_complaint_en": ["Flank Pain", "Hematuria"], "system_en": ["Oncologic", "Renal", "Urinary"], "search_abbreviation_en": ["RCC", "TNM", "tumor", "lymph node", "mets", "metastasis"], "slug": "tnm-staging-renal-cell-carcinoma", "seo": {"meta_description_en": "The TNM Staging for Renal Cell Carcinoma Provides information about the severity of renal cell cancer based on tumor, lymph node, and metastasis characteristics.", "keywords_en": "tnm, rcc ca, rcc cancer, rcc CA tnm, situ, lobular rcc ca, rcc tumor, rcc lymph, rcc mets, rcc metastasis, TNM Staging for rcc cancer, rcc cancer, rcc ca, kidney cancer cancer, kidney ca, kidney ca tnm, rcc cancer tnm, rcc cancer staging, renal, ca, cancer, renal cell carcinoma, renal cell clear cell, kidney cancer, chronic, prognosis"}, "content": {"how_to_use": {"use_case_en": "<p>Patients with RCC.</p>", "pearls_pitfalls_en": "<p>The Union for International Cancer Control (UICC) TNM Staging System, updated in 2010, is broadly used to help prognose in RCC. The prognosis estimates are based on cancer-specific survival (not overall). There is overlap between some categories, and it is unclear if it can apply to modern targeted treatments, but the system has performed well where tested.</p>", "why_use_en": "<p>Staging RCC may help sketch categories of survival time better than clinical judgment alone. In addition, the TNM system is a necessary input for some other, more refined prognosis scores (e.g. <calculator id=\"3009\">UCLA/UISS</calculator>, <calculator id=\"2154\">SSIGN</calculator>).</p>"}, "next_steps": {"advice_en": "<p>The TNM staging system offers an orderly progression of worsening prognosis estimates in most validation studies. There is controversy over some subcategories (e.g. T2a versus T2b) where estimates overlap, and the system has not, to our knowledge, been validated in populations treated with modern targeted therapies.</p>", "management_en": "<p>We are unaware of validated management algorithms using the score.</p>", "critical_actions_en": "<p>The TNM staging system is not proven to be accurate for individual survival prediction and should be considered a general guide rather than a reliable predictor.</p>"}, "about": {"formula_en": "<p>Staging based on multiple factors including:</p> <ul> <li>Primary tumor (T) characteristics</li> <li>Regional lymph nodes (N) <ul> <li>Clinical</li> <li>Pathological</li> </ul> </li> <li>Distant metastasis (M)</li> </ul>", "more_info_en": "<div class=\"table-responsive\"> <table class=\"table table-bordered table-hover\"> <tbody> <tr> <th>T stage</th> <th>5 Year Cancer Specific Survival</th> </tr> <tr> <td>T1a</td> <td>94.9%</td> </tr> <tr> <td>T1b</td> <td>92.6%</td> </tr> <tr> <td>T2a</td> <td>85.4%</td> </tr> <tr> <td>T2b</td> <td>70.0%</td> </tr> <tr> <td>T3a</td> <td>64.7%</td> </tr> <tr> <td>T3b</td> <td>54.7%</td> </tr> <tr> <td>T3c</td> <td>17.9%</td> </tr> <tr> <td>T4</td> <td>24.7%</td> </tr> </tbody> </table> </div>", "evidence_based_medicine_en": "", "references_list": {"Original/Primary Reference": [{"text": "Kidney. In: Edge SB, Byrd DR, Compton CC, et al., eds.: AJCC Cancer Staging Manual. 7th ed."}], "Other References": [{"href": "https://www.nccn.org/professionals/physician_gls/f_guidelines.asp", "text": "NCCN Clinical Practice Guidelines in Oncology: Kidney Cancer. V 2.2014. Accessed: September 15, 2015."}, {"href": "http://www.ajronline.org/doi/full/10.2214/AJR.07.3568", "text": "Chaan S. Ng, Christopher G. Wood, Paul M. Silverman, Nizar M. Tannir, Pheroze Tamboli, and Carl M. Sandler"}, {"href": "https://www.cornellurology.com/clinical-conditions/kidney-cancer/renal-cell-carcinoma/#Staging", "text": "Weill Cornell Medical College James Buchanan Brady Foundation Department of Urology. Renal Cell Carcinoma. Accessed: September, 20, 2015."}, {"href": "http://www.ncbi.nlm.nih.gov/pubmed/11037491?dopt=Abstract", "text": "Choyke PL, Amis ES Jr, Bigongiari LR, Bluth EI, Bush WH Jr, Fritzsche P, Holder L, Newhouse JH, Sandler CM, Segal AJ, Resnick MI, Rutsky EA. Renal cell carcinoma staging. American College of Radiology. ACR Appropriateness Criteria. Radiology. 2000 Jun;215 Suppl:721-5"}], "Validation": [{"href": "http://www.esmo.org/Guidelines/Genitourinary-Cancers/Renal-Cell-Carcinoma", "text": "Escudier B, et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2014) 25 (suppl 3): iii49-iii56."}, {"href": "https://www.ncbi.nlm.nih.gov/pubmed/20674150", "text": "Novara G, et. al. Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? Eur Urol. 2010 Oct;58(4):588-95. doi: 10.1016/j.eururo.2010.07.006. Epub 2010 Jul 23."}], "Clinical Practice Guidelines": [{"href": "", "text": ""}], "Manufacturer Website": [{"href": "", "text": ""}], "Outcomes": [{"href": "", "text": ""}]}}, "contributor": {"expert_name": []}, "reviewer": {"expert_name": []}, "creator": [{"name": "Dr. Stephen Edge", "creator_info": {"about_en": "<p>Stephen B. Edge, MD, FACS, FASCO, is an adjunct professor of surgery at Vanderbilt University and the current director of the Baptist Cancer Center. Dr. Edge has co-chaired the 2010 Breast Cancer Symposium and Guideline Panel for Postmastectomy Radiation and is serving on the editorial board of the Journal of Oncology Practice. His research focuses on staging systems and risk stratification for many types of cancers.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-stephen-edge.jpeg", "pubmedLink": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Edge+SB%5BAuthor%5D"}}], "related_resources": {"mdcalc_rating": {"evidence": "", "clinical": "", "popularity": ""}, "guidelines": [], "teaching": [], "videos": [], "interests": [{"link": "https://www.mdcalc.com/rcc-renal-cell-carcinoma-practice-pearls", "text": "Practice Pearls: Renal Cell Carcinoma"}], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"type": "radio", "label_en": "Primary tumor (T)", "name": "t", "options": [{"label": "No evidence of primary tumor", "value": 2}, {"label": "Organ confined, \u22644 cm", "value": 3}, {"label": "Organ confined, 4-7 cm", "value": 4}, {"label": "Organ confined, 7-10 cm", "value": 5}, {"label": "Organ confined, >10 cm", "value": 6}, {"label": "Perinephric tissue, renal sinus, or renal vein", "value": 7}, {"label": "Vena cava below the diaphragm", "value": 8}, {"label": "Vena cava above diaphragm or into wall of vena cava at any level", "value": 9}, {"label": "Beyond Gerota\u2019s fascia or directly into adrenal gland", "value": 10}, {"label": "Primary tumor cannot be assessed", "value": 1}], "conditionality": "", "show_points": false, "optional": false}, {"type": "radio", "label_en": "Regional lymph nodes (N)", "name": "n", "options": [{"label": "No regional lymph node metastasis", "value": 2}, {"label": "Metastasis in a single regional lymph node", "value": 3}, {"label": "Metastasis in more than one regional lymph node", "value": 4}, {"label": "Regional nodes cannot be assessed", "value": 1}], "conditionality": "", "show_points": false, "optional": false}, {"type": "radio", "label_en": "Distant metastasis (M)", "name": "m", "options": [{"label": "No distant metastasis", "value": 2}, {"label": "Distant metastasis", "value": 3}, {"label": "Distant metastasis cannot be assessed", "value": 1}], "conditionality": "", "show_points": false, "optional": false}], "md5": "9eed38878cd0958494275cd3ad12755c", "related_calcs": [{"calcId": 10122, "short_title_en": "TNM RCC Staging (8th Ed.)", "slug": "tnm-staging-renal-cell-carcinoma-rcc-8th-edition"}, {"calcId": 3009, "short_title_en": "UISS for RCC", "slug": "ucla-integrated-staging-system-uiss-renal-cell-carcinoma-rcc"}, {"calcId": 3008, "short_title_en": "IMDC Model for mRCC", "slug": "imdc-international-metastatic-rcc-database-consortium-risk-model-metastatic-renal-cell-carcinoma"}]}